These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 26681659)
1. Computer-aided diagnosis for estimating the malignancy grade of hepatocellular carcinoma using contrast-enhanced ultrasound: an ROC observer study. Sugimoto K; Shiraishi J; Tanaka H; Tsuchiya K; Aso K; Kobayashi Y; Iijima H; Moriyasu F Liver Int; 2016 Jul; 36(7):1026-32. PubMed ID: 26681659 [TBL] [Abstract][Full Text] [Related]
2. Utility of Contrast-enhanced Ultrasonography with Perflubutane for Determining Histologic Grade in Hepatocellular Carcinoma. Tada T; Kumada T; Toyoda H; Ito T; Sone Y; Kaneoka Y; Maeda A; Okuda S; Otobe K; Takahashi K Ultrasound Med Biol; 2015 Dec; 41(12):3070-8. PubMed ID: 26360976 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of contrast-enhanced ultrasound washout rate in predicting hepatocellular carcinoma differentiation. Feng Y; Qin XC; Luo Y; Li YZ; Zhou X Ultrasound Med Biol; 2015 Jun; 41(6):1553-60. PubMed ID: 25747937 [TBL] [Abstract][Full Text] [Related]
4. Evaluating histologic differentiation of hepatitis B virus-related hepatocellular carcinoma using intravoxel incoherent motion and AFP levels alone and in combination. Shan Q; Chen J; Zhang T; Yan R; Wu J; Shu Y; Kang Z; He B; Zhang Z; Wang J Abdom Radiol (NY); 2017 Aug; 42(8):2079-2088. PubMed ID: 28337521 [TBL] [Abstract][Full Text] [Related]
5. [Early diagnosis of small hepatocellular carcinoma by new contrast-enhanced ultrasound technique]. Chen MH; Dai Y; Yan K; Fan ZH; Wu W; Wang YB; Yin SS; Yang W; Li JY Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):458-62. PubMed ID: 16224512 [TBL] [Abstract][Full Text] [Related]
6. Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma: correlation with enhancement degree and histologic grade. Woo S; Lee JM; Yoon JH; Joo I; Han JK; Choi BI Radiology; 2014 Mar; 270(3):758-67. PubMed ID: 24475811 [TBL] [Abstract][Full Text] [Related]
7. Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound. Chen LD; Ruan SM; Liang JY; Yang Z; Shen SL; Huang Y; Li W; Wang Z; Xie XY; Lu MD; Kuang M; Wang W World J Gastroenterol; 2018 Sep; 24(33):3786-3798. PubMed ID: 30197484 [TBL] [Abstract][Full Text] [Related]
8. Differentiation of Atypical Hepatocellular Carcinoma from Focal Nodular Hyperplasia: Diagnostic Performance of Contrast-enhanced US and Microflow Imaging. Li W; Wang W; Liu GJ; Chen LD; Wang Z; Huang Y; Liu JY; Xie XY; Lu MD Radiology; 2015 Jun; 275(3):870-9. PubMed ID: 25584708 [TBL] [Abstract][Full Text] [Related]
9. New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography. Tanaka H; Iijima H; Higashiura A; Yoh K; Ishii A; Takashima T; Sakai Y; Aizawa N; Iwata K; Ikeda N; Iwata Y; Enomoto H; Saito M; Imanishi H; Hirota S; Fujimoto J; Nishiguchi S J Gastroenterol; 2014 Apr; 49(4):755-63. PubMed ID: 23720089 [TBL] [Abstract][Full Text] [Related]
10. Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma. Arita J; Hasegawa K; Takahashi M; Hata S; Shindoh J; Sugawara Y; Kokudo N AJR Am J Roentgenol; 2011 Jun; 196(6):1314-21. PubMed ID: 21606294 [TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma. Takahashi M; Maruyama H; Ishibashi H; Yoshikawa M; Yokosuka O AJR Am J Roentgenol; 2011 Feb; 196(2):W123-31. PubMed ID: 21257852 [TBL] [Abstract][Full Text] [Related]
12. Prediction of histological grade of hepatocellular carcinoma using quantitative diffusion-weighted MRI: a retrospective multivendor study. Ogihara Y; Kitazume Y; Iwasa Y; Taura S; Himeno Y; Kimura T; Sawano S; Terada S; Tanabe M; Saida Y; Tateishi U Br J Radiol; 2018 Apr; 91(1084):20170728. PubMed ID: 29271235 [TBL] [Abstract][Full Text] [Related]
13. Parametric imaging with contrast-enhanced ultrasound for differentiating hepatocellular carcinoma from metastatic liver cancer. Yue WW; Wang S; Xu HX; Sun LP; Guo LH; Bo XW; Li XL; Zhao CK; Wang D; Liu BJ Clin Hemorheol Microcirc; 2016 Nov; 64(2):177-188. PubMed ID: 27258196 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography. Shiozawa K; Watanabe M; Takayama R; Takahashi M; Wakui N; Iida K; Sumino Y J Clin Ultrasound; 2010 May; 38(4):182-9. PubMed ID: 20232404 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings. Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131 [TBL] [Abstract][Full Text] [Related]
16. Computer-aided diagnosis for the classification of focal liver lesions by use of contrast-enhanced ultrasonography. Shiraishi J; Sugimoto K; Moriyasu F; Kamiyama N; Doi K Med Phys; 2008 May; 35(5):1734-46. PubMed ID: 18561648 [TBL] [Abstract][Full Text] [Related]
17. Quantitative free-breathing dynamic contrast-enhanced MRI in hepatocellular carcinoma using gadoxetic acid: correlations with Ki67 proliferation status, histological grades, and microvascular density. Chen J; Chen C; Xia C; Huang Z; Zuo P; Stemmer A; Song B Abdom Radiol (NY); 2018 Jun; 43(6):1393-1403. PubMed ID: 28939963 [TBL] [Abstract][Full Text] [Related]
18. Prostate cancer: computer-aided diagnosis with multiparametric 3-T MR imaging--effect on observer performance. Hambrock T; Vos PC; Hulsbergen-van de Kaa CA; Barentsz JO; Huisman HJ Radiology; 2013 Feb; 266(2):521-30. PubMed ID: 23204542 [TBL] [Abstract][Full Text] [Related]
19. The Degree of Contrast Washout on Contrast-Enhanced Ultrasound in Distinguishing Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma. Han J; Liu Y; Han F; Li Q; Yan C; Zheng W; Wang J; Guo Z; Wang J; Li A; Zhou J Ultrasound Med Biol; 2015 Dec; 41(12):3088-95. PubMed ID: 26386477 [TBL] [Abstract][Full Text] [Related]
20. Combined Hepatocellular Cholangiocarcinoma (Biphenotypic) Tumors: Potential Role of Contrast-Enhanced Ultrasound in Diagnosis. Li F; Han J; Han F; Wang JW; Luo RZ; Li AH; Zhou JH AJR Am J Roentgenol; 2017 Oct; 209(4):767-774. PubMed ID: 28777653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]